Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free AVR Stock Alerts

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$9.40 +0.47 (+5.26%)
Closing price 04:00 PM Eastern
Extended Trading
$9.18 -0.23 (-2.39%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

AVR vs. PLSE, TMDX, AXGN, BFLY, and ESTA

Should you buy Anteris Technologies Global stock or one of its competitors? Anteris Technologies Global's main competitors and comparable companies include Pulse Biosciences (PLSE), TransMedics Group (TMDX), AxoGen (AXGN), Butterfly Network (BFLY), and Establishment Labs (ESTA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Anteris Technologies Global compare to Pulse Biosciences?

Anteris Technologies Global (NASDAQ:AVR) and Pulse Biosciences (NASDAQ:PLSE) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

77.0% of Pulse Biosciences shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 74.0% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Anteris Technologies Global presently has a consensus target price of $16.00, suggesting a potential upside of 70.21%. Pulse Biosciences has a consensus target price of $41.00, suggesting a potential downside of 7.95%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, equities analysts plainly believe Anteris Technologies Global is more favorable than Pulse Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Pulse Biosciences
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Anteris Technologies Global had 13 more articles in the media than Pulse Biosciences. MarketBeat recorded 22 mentions for Anteris Technologies Global and 9 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.36 beat Anteris Technologies Global's score of 0.22 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral
Pulse Biosciences
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Anteris Technologies Global has a net margin of -4,619.27% compared to Pulse Biosciences' net margin of -6,755.78%. Anteris Technologies Global's return on equity of -77.69% beat Pulse Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies Global-4,619.27% -77.69% -67.99%
Pulse Biosciences -6,755.78%-94.42%-79.96%

Pulse Biosciences has lower revenue, but higher earnings than Anteris Technologies Global. Pulse Biosciences is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$1.91M479.65-$94.14M-$1.95N/A
Pulse Biosciences$350K8,807.47-$72.78M-$1.18N/A

Anteris Technologies Global has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

Summary

Anteris Technologies Global beats Pulse Biosciences on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

TransMedics Group presently has a consensus price target of $124.18, indicating a potential upside of 40.19%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 70.21%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

TransMedics Group has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$605.49M5.06$190.29M$3.8922.77
Anteris Technologies Global$1.91M479.65-$94.14M-$1.95N/A

99.7% of TransMedics Group shares are held by institutional investors. 6.9% of TransMedics Group shares are held by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Anteris Technologies Global had 15 more articles in the media than TransMedics Group. MarketBeat recorded 22 mentions for Anteris Technologies Global and 7 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.34 beat Anteris Technologies Global's score of 0.22 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Anteris Technologies Global
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral

TransMedics Group has a net margin of 22.69% compared to Anteris Technologies Global's net margin of -4,619.27%. TransMedics Group's return on equity of 15.88% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group22.69% 15.88% 5.95%
Anteris Technologies Global -4,619.27%-77.69%-67.99%

TransMedics Group has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.78, indicating that its share price is 78% more volatile than the broader market.

Summary

TransMedics Group beats Anteris Technologies Global on 12 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to AxoGen?

Anteris Technologies Global (NASDAQ:AVR) and AxoGen (NASDAQ:AXGN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Anteris Technologies Global presently has a consensus target price of $16.00, indicating a potential upside of 70.21%. AxoGen has a consensus target price of $51.00, indicating a potential upside of 4.66%. Given Anteris Technologies Global's higher probable upside, equities analysts clearly believe Anteris Technologies Global is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
AxoGen
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73

AxoGen has higher revenue and earnings than Anteris Technologies Global. AxoGen is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$1.91M479.65-$94.14M-$1.95N/A
AxoGen$225.21M11.63-$15.70M-$0.68N/A

80.3% of AxoGen shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 2.4% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Anteris Technologies Global had 9 more articles in the media than AxoGen. MarketBeat recorded 22 mentions for Anteris Technologies Global and 13 mentions for AxoGen. AxoGen's average media sentiment score of 0.53 beat Anteris Technologies Global's score of 0.22 indicating that AxoGen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral
AxoGen
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AxoGen has a net margin of -13.36% compared to Anteris Technologies Global's net margin of -4,619.27%. AxoGen's return on equity of -8.90% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies Global-4,619.27% -77.69% -67.99%
AxoGen -13.36%-8.90%-6.47%

Anteris Technologies Global has a beta of 1.78, meaning that its share price is 78% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market.

Summary

AxoGen beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

Butterfly Network has a net margin of -66.74% compared to Anteris Technologies Global's net margin of -4,619.27%. Butterfly Network's return on equity of -33.99% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-66.74% -33.99% -22.96%
Anteris Technologies Global -4,619.27%-77.69%-67.99%

Butterfly Network currently has a consensus target price of $5.56, suggesting a potential downside of 37.19%. Anteris Technologies Global has a consensus target price of $16.00, suggesting a potential upside of 70.21%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

37.9% of Butterfly Network shares are held by institutional investors. 22.0% of Butterfly Network shares are held by insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Butterfly Network has higher revenue and earnings than Anteris Technologies Global. Butterfly Network is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$97.61M24.16-$77.06M-$0.29N/A
Anteris Technologies Global$1.91M479.65-$94.14M-$1.95N/A

Butterfly Network has a beta of 2.09, suggesting that its stock price is 109% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.78, suggesting that its stock price is 78% more volatile than the broader market.

In the previous week, Anteris Technologies Global had 9 more articles in the media than Butterfly Network. MarketBeat recorded 22 mentions for Anteris Technologies Global and 13 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.54 beat Anteris Technologies Global's score of 0.22 indicating that Butterfly Network is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
6 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Anteris Technologies Global
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral

Summary

Butterfly Network beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Establishment Labs has a net margin of -15.82% compared to Anteris Technologies Global's net margin of -4,619.27%. Anteris Technologies Global's return on equity of -77.69% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-15.82% -196.69% -10.73%
Anteris Technologies Global -4,619.27%-77.69%-67.99%

Establishment Labs has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.78, meaning that its stock price is 78% more volatile than the broader market.

Establishment Labs has higher revenue and earnings than Anteris Technologies Global. Establishment Labs is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$211.08M11.22-$51.06M-$1.31N/A
Anteris Technologies Global$1.91M479.65-$94.14M-$1.95N/A

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 26.15%. Anteris Technologies Global has a consensus price target of $16.00, suggesting a potential upside of 70.21%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Establishment Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Anteris Technologies Global had 12 more articles in the media than Establishment Labs. MarketBeat recorded 22 mentions for Anteris Technologies Global and 10 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.93 beat Anteris Technologies Global's score of 0.22 indicating that Establishment Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Anteris Technologies Global
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral

Summary

Establishment Labs beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

Export
MetricAnteris Technologies GlobalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$870.30M$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E Ratio-4.8226.22269.0625.28
Price / Sales479.6563.09602.4391.76
Price / CashN/A33.9270.4850.90
Price / Book3.646.1012.916.24
Net Income-$94.14M$148.67M$3.45B$347.60M
7 Day Performance5.50%1.84%1.12%1.07%
1 Month Performance5.03%4.56%1.79%1.03%
1 Year Performance139.80%8.67%67.69%20.77%

Anteris Technologies Global Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
2.8612 of 5 stars		$9.40
+5.3%		$16.00
+70.2%		+120.0%$870.30M$1.91MN/A138
PLSE
Pulse Biosciences
0.9895 of 5 stars		$41.51
-2.1%		$36.00
-13.3%		+167.5%$2.94B$350KN/A140
TMDX
TransMedics Group
4.4617 of 5 stars		$88.41
+5.4%		$124.18
+40.5%		-32.1%$2.90B$605.49M42.58210
AXGN
AxoGen
2.4851 of 5 stars		$48.22
+3.9%		$51.00
+5.8%		+225.5%$2.50B$225.21MN/A450
BFLY
Butterfly Network
0.9461 of 5 stars		$9.71
+10.0%		$5.56
-42.7%		+529.5%$2.35B$97.61MN/A460

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AVR) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Why I'm sending this one to my own family
Behind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...
Behind the Markets | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The Shocking Discovery Investigators Found Hidden Inside America's Port Cranes
U.S. investigators found unexplained cellular modems inside cranes made by a Chinese state-owned company that ...
Altimetry | Sponsoredtc pixel